Redwood Investments, LLC Exelixis, Inc. Transaction History

Redwood Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $1.66 Million - $2.38 Million	-74,774 Reduced 70.45%	31,357 $695,000
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $279,783 - $357,148	11,547 Added 12.21%	106,131 $3.23 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $2.21 Million - $2.77 Million	94,584	94,584 $2.29 Million

508

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.